Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...
Auteurs principaux: | Borchert, GA, Shamsnajafabadi, H, Ng, BWJ, Xue, K, De Silva, SR, Downes, SM, MacLaren, RE, Cehajic-Kapetanovic, J |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Frontiers Media
2024
|
Documents similaires
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
par: Grace A. Borchert, et autres
Publié: (2024-07-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
par: Grace A. Borchert, et autres
Publié: (2023-08-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
par: Michelle E. McClements, et autres
Publié: (2020-11-01) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
par: Borchert, GA, et autres
Publié: (2024) -
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
par: Hoda Shamsnajafabadi, et autres
Publié: (2023-08-01)